Metastatic clinical trials at University of California Health

1 in progress, 0 open to eligible people

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
Sorry, not currently recruiting here
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer
at UC Davis

Last updated: February 14, 2023